Clinical Trial

CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR

Study acronym: CPAP-RT
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
A phase II trial to determine the proportion of patients where the use of continuous positive airway pressure (CPAP) results in a superior radiation plan compared to standard planning procedures. The rationale for using CPAP with radiotherapy is based on its ability to increase the tidal volume, flatten the diaphragm thus reducing respiratory excursions.The resultant lung hyperinflation and reduced respiratory excursions can be harnessed for radiotherapy purposes by: 1. Displacing the heart away from the radiotherapy field 2. Reducing the volume of functional lung irradiated 3. Reducing the radiotherapy target motion CPAP has been shown to be superior to free breathing radiotherapy (RT), however it remains unclear how much benefit it confers vs other motion management adjuncts such as deep inspiration breath hold (DIBH) or 4-DCT.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT05396950
Lead Sponsor Waikato Hospital
Conditions Cancer
Enrollment 70 participants
Start Date 2025-10
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-04-24